Chir-258
Advanced/ Metastatic Renal Cell Cancer
Novartis PharmaceuticalsPhase 3
—
Rating in progress
Chir-258 in Advanced/ Metastatic Renal Cell Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant